Hubertus Degen

TCT-38 Two-Year Clinical Data Of Cohort 1 And Multi-Modality Imaging Results Up To 1-Year Follow-Up Of The BIOSOLVE-I Study With The Paclitaxel-Eluting Bioabsorbable Magnesium Scaffold (DREAMS)

Raimund Erbel, Francesco Prati, Michael Haude, 2012 .

Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial

Raimund Erbel, Neil Weissman, Francesco Prati, 2013, The Lancet.